Martin Shkreli, the CEO of Retrophin Pharmaceuticals, has been found guilty of defrauding investors.

He was best known for raising the price of a life-saving HIV drug.

Shkreli remains free on bail until he returns to court for sentencing when he could get up to 20 years.

Al Jazeera's Kristen Saloomey reports from New York City.

United States